Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Laduron

Showing results (111-120 of 133) with videos related to

Pageof 14
Sort By:
Life Sciences|August 7, 1978
Inhibition of dopamine receptors in the stomach: an explanation of the gastrokinetic properties of domperidoneJ M Van Nueten, C Ennis, L Helsen, et al.
European Journal of Pharmacology|August 21, 1987
Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distributionP Kitabgi, W Rostène, M Dussaillant, et al.
Journal of Neurochemistry|February 1, 1986
Different subcellular localization of muscarinic and serotonin (S2) receptors in human, dog, and rat brainM K Luabeya, J M Maloteaux, C De Roe, et al.
British Journal of Pharmacology|May 1, 1993
A non-peptide NK1-receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynapticallyS M Moussaoui, F Montier, A Carruette, et al.
Neuropeptides|May 1, 1990
Ethanol and opiate decrease the axonal transport of substance-P like immunoreactive material in rat vagus-nervesP A De Witte, M Hamon, A Mauborgne, et al.
Life Sciences|March 2, 1981
Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptorsJ E Leysen, F Awouters, L Kennis, et al.
European Journal of Pharmacology|November 8, 1988
[3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsyJ M Maloteaux, M A Vanisberg, C Laterre, et al.
Molecular Pharmacology|June 1, 1985
Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonistJ E Leysen, W Gommeren, P Van Gompel, et al.
Regulatory Peptides|July 2, 1993
Antinociceptive properties and inhibition of neurogenic inflammation with potent SP antagonists belonging to perhydroisoindolonesC Garret, A Carruette, V Fardin, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1992
[RP 67580, a potent and selective substance P non-peptide antagonist]C Garret, A Carruette, V Fardin, et al.
Pageof 14

Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Life Sciences|August 7, 1978
Inhibition of dopamine receptors in the stomach: an explanation of the gastrokinetic properties of domperidoneJ M Van Nueten, C Ennis, L Helsen, et al.
European Journal of Pharmacology|August 21, 1987
Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distributionP Kitabgi, W Rostène, M Dussaillant, et al.
Journal of Neurochemistry|February 1, 1986
Different subcellular localization of muscarinic and serotonin (S2) receptors in human, dog, and rat brainM K Luabeya, J M Maloteaux, C De Roe, et al.
British Journal of Pharmacology|May 1, 1993
A non-peptide NK1-receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynapticallyS M Moussaoui, F Montier, A Carruette, et al.
Neuropeptides|May 1, 1990
Ethanol and opiate decrease the axonal transport of substance-P like immunoreactive material in rat vagus-nervesP A De Witte, M Hamon, A Mauborgne, et al.
Life Sciences|March 2, 1981
Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptorsJ E Leysen, F Awouters, L Kennis, et al.
European Journal of Pharmacology|November 8, 1988
[3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsyJ M Maloteaux, M A Vanisberg, C Laterre, et al.
Molecular Pharmacology|June 1, 1985
Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonistJ E Leysen, W Gommeren, P Van Gompel, et al.
Regulatory Peptides|July 2, 1993
Antinociceptive properties and inhibition of neurogenic inflammation with potent SP antagonists belonging to perhydroisoindolonesC Garret, A Carruette, V Fardin, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1992
[RP 67580, a potent and selective substance P non-peptide antagonist]C Garret, A Carruette, V Fardin, et al.
Pageof 14